Rising Adoption of Mass Spectrometry in Pharmaceutical and Environmental Analysis Will Drive Market Growth

The global mass spectrometry market is expected to reach $5.27 billion by 2022. Factors such as technological advancements in mass spectrometry, government initiatives for pollution control and environmental testing, increasing spending on pharmaceutical R&D across the globe, growing petrochemical industry, and growing focus on ensuring the quality of food products are driving the growth of the mass spectrometry market.

mass-spectrometry-market5 (1)

A major concern with mass spectrometry technique is that the spectrometry instruments are priced at a higher side owing to them being equipped with advanced features and functionalities. Although the technological advancements in mass spectrometry have increased their demand over the years, they have resulted in an increase in the prices of these systems.

The price of a spectrometer influences the purchase decision of end users. Pharmaceutical companies require large numbers of such systems and hence, the capital cost increases significantly. Furthermore, academic research laboratories find it difficult to afford such systems as they have controlled budgets. These are the major factors limiting the wider adoption of mass spectrometry systems among end users.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=437

However, growth in target markets in emerging nations like China and India is likely to present an array of lucrative growth opportunities for players in the mass spectrometry market in the coming years.

As imports of pharmaceuticals from China and India have increased in the US, there is a growing focus on QC processes in the manufacturing units in these countries as they are required to follow the regulations/guidelines set by the US Pharmacopeia (USP), which regulates even trace amounts of elements in final products. Overall, this scenario is favorable for the greater adoption of mass spectrometry instruments in the pharmaceutical industries in these countries.

Enhanced technology, increased sensitivity, accuracy & efficiency, along with the capacity to yield large volumes of complex data at high speed and resolution are driving the growth of the hybrid mass spectrometers segment.

Know More: https://www.marketsandmarkets.com/Market-Reports/mass-spectrometry-market-437.html

Share this post:

Related Posts

Comments are closed.